AFLAC INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.28 USD | +0.63% |
|
+4.79% | +2.16% |
| Apr. 15 | Morgan Stanley Raises Price Target on Aflac to $84 From $80, Maintains Equalweight Rating | MT |
| Apr. 11 | Wells Fargo Cuts Price Target on Aflac to $81 From $83, Keeps Equalweight Rating | MT |
Financials (USD)
| Sales 2024 * | 17.17B | Sales 2025 * | 17.5B | Capitalization | 48.19B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.57B | Net income 2025 * | 3.64B | EV / Sales 2024 * | 3.02 x |
| Net Debt 2024 * | 3.74B | Net Debt 2025 * | 3.06B | EV / Sales 2025 * | 2.93 x |
| P/E ratio 2024 * |
13.4
x | P/E ratio 2025 * |
12.5
x | Employees | 12,785 |
| Yield 2024 * |
2.3% | Yield 2025 * |
2.42% | Free-Float | 38.38% |
More Fundamentals
* Assessed data
More news
Latest transcript on Aflac Incorporated
More recommendations
More press releases
| 1 day | +0.63% | ||
| 1 week | +4.79% | ||
| Current month | -1.84% | ||
| 1 month | +0.14% | ||
| 3 months | -0.43% | ||
| 6 months | +9.23% | ||
| Current year | +2.16% |
1 week
80.11
84.46
1 month
79.3186.26
Current year
75.0886.26
1 year
64.1086.26
3 years
51.2886.26
5 years
23.0786.26
10 years
23.0786.26
| Managers | Title | Age | Since |
|---|---|---|---|
Dan Amos
CEO | Chief Executive Officer | 72 | 72-12-31 |
Max Brodén
DFI | Director of Finance/CFO | 45 | 17-04-02 |
Thomas McDaniel
CMP | Compliance Officer | - | 03-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dan Amos
CEO | Chief Executive Officer | 72 | 72-12-31 |
Barbara Rimer
BRD | Director/Board Member | 75 | 94-12-31 |
William Bowers
BRD | Director/Board Member | 67 | 12-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.14% | 204 M€ | +10.54% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 84.28 | +0.63% | 2,311,393 |
| 24-04-23 | 83.75 | +0.28% | 1,764,459 |
| 24-04-22 | 83.52 | +0.35% | 1,809,298 |
| 24-04-19 | 83.23 | +2.78% | 6,558,436 |
| 24-04-18 | 80.98 | +0.90% | 2,129,906 |
Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT
More quotes
Aflac Incorporated is a life insurance group organized around 3 sectors of activity:
- sale of health and life insurance products in Japan (57.7% of net sales): including cancer life plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities;
- sale of health and life insurance products in the United States (39.5%): including accident/disability plans, cancer expense plans, short-term disability plans, sickness and hospital indemnity plans, hospital intensive care plans, fixed-benefit dental plans, vision care plans, and long-term care plans;
- other (2.8%).
Sector
Life & Health Insurance
Calendar
2024-04-30
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
83.75
USD
Average target price
84.54
USD
Spread / Average Target
+0.94%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.16% | 48.19B | |
| +16.14% | 82.2B | |
| +9.97% | 52.22B | |
| +9.84% | 42.44B | |
| +8.73% | 40.27B | |
| +20.54% | 38.35B | |
| +3.11% | 30.18B | |
| -7.82% | 27.48B | |
| -17.13% | 25.31B | |
| +7.65% | 21.95B |
- Stock Market
- Equities
- AFL Stock
